The project
Since 2014, the Spanish Society of Hospital Pharmacy (SEFH) has been steadily promoting the MAPEX project as a strategic initiative aimed at understanding, anticipating, and responding to the present and future needs of people receiving outpatient care in hospital pharmacies. This work has been carried out in an integrated manner in the areas of healthcare, teaching, and research, with the hospital pharmacist as a key agent of leadership and transformation.
Over more than a decade of evolution, MAPEX has made it possible to build a solid strategic framework that articulates actions at the macro, meso, and micro levels of the healthcare system. This framework brings together documents, models, and tools aimed at facilitating a measurable and relevant contribution by Hospital Pharmacy to improving health outcomes, in a context marked by sustained growth in the number of outpatients and an increase in their clinical, therapeutic, and social complexity.
This process has defined and consolidated a person-centered model of pharmaceutical care based on the CMO (Capacity–Motivation–Opportunity) methodology, which has served as the basis for the development of healthcare stratification models, the effective integration of pharmacists into multidisciplinary teams, the development of clinical practice guidelines adapted to different pathologies, and the progressive implementation of remote pharmaceutical care modalities and longitudinal follow-up.
As an expression of its commitment to quality, evaluation, and continuous improvement, MAPEX has also promoted a pioneering standard for the certification of pharmaceutical care in outpatient consultations (Q-PEX), aligned with standards of excellence, methodological rigor, and results orientation. Currently, more than 20 hospitals in Spain are already certified or recertified, and the number continues to rise.
The project's progress has been based on a collaborative and participatory approach, materialized in consensus conferences, situation studies, and spaces for shared reflection, which have allowed MAPEX to adapt to changes in the healthcare environment and new professional and organizational demands.
In 2026, MAPEX is in a phase of consolidation and national and international expansion, with a mature conceptual and operational foundation, and with the goal of continuing to evolve as a dynamic framework for the transformation of hospital pharmaceutical care.
The fundamental principle of the MAPEX project is to place the patient at the center of hospital pharmacy, guiding professional practice toward a more personalized, efficient model focused on achieving health outcomes.